Jane Chung - 05 Mar 2024 Form 4 Insider Report for SUTRO BIOPHARMA, INC. (STRO)

Role
PRESIDENT AND COO
Signature
/s/ Edward C. Albini as attorney-in-fact for Jane Chung
Issuer symbol
STRO
Transactions as of
05 Mar 2024
Net transactions value
$0
Form type
4
Filing time
07 Mar 2024, 16:26:46 UTC
Previous filing
06 Mar 2024
Next filing
24 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STRO Stock Option (Right to Buy Common Stock) Award $0 +50,000 $0.000000 50,000 05 Mar 2024 Common Stock 50,000 $4.54 Direct F1
transaction STRO Restricted Stock Units (RSUs) Award $0 +100,000 $0.000000 100,000 05 Mar 2024 Common Stock 100,000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 2.0833% of the total award monthly, beginning on April 1, 2024, with 100% of the award being vested and exercisable on March 1, 2028, subject to the reporting person's continued service to the Issuer on each vesting date.
F2 Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
F3 The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date.